Raises FY26 adjusted EBITDA view to $120M-$124M from $115M-$118M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRDN:
- GRDN Upcoming Earnings Report: What to Expect?
- Guardian Pharmacy price target raised to $36 from $35 at Stephens
- Guardian Pharmacy Reaffirms 2025 Outlook, Issues 2026 Guidance
- Guardian Pharmacy affirms FY25 revenue view of $1.43B-$1.45B, consensus $1.44B
- Guardian Pharmacy sees FY26 revenue of $1.40B-$1.42B, consensus $1.45B